LOINC Code 93022-2: Multiple myeloma minimal residual disease panel FC (BM)
93022-2 is a LOINC code used to identify Multiple myeloma minimal residual disease panel FC (BM) in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Multiple myeloma minimal residual disease panel. It is commonly used with the system or sample type Bone mar.
What is this code?
LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Multiple myeloma minimal residual disease panel. It is commonly used with the system or sample type Bone mar.
When is it used?
- Used in lab systems, EHRs, and clinical data exchange.
- May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
- Status: ACTIVE
- Order vs observation: Order
- Panel type: Panel
- Method: Flow cytometry
What it does not mean
- The code identifies the observation or test, not the actual result.
Key facts
- Multiple myeloma minimal residual disease panel - Bone marrow by Flow cytometry (FC)
- Multiple myeloma minimal residual disease panel
- This panel contains test results for the assessment of minimal residual disease (MRD) in multiple myeloma patients during and after treatment.
- BM; BON; Bone marrow; Dis; Diseases; Dynamic; Dz; FC; HEMATOLOGY/CELL COUNTS; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Mult; Multi; Multiple myeloma MRD Pnl; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; Random
Where you may see this code
You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.
Common synonyms
Frequently asked questions
About this content
This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.